LESLIE BEBEN: Open Payments
NPI 1417941501 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$223 in 10 payments from 8 companies in 2025. Trend: 2023 $952 · 2024 $774 · 2025 $223
Food & beverage: $223
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 2 | $72 |
| Amgen Inc. | 2 | $35 |
| Dexcom, Inc. | 1 | $25 |
| ABBVIE INC. | 1 | $21 |
| PFIZER INC. | 1 | $18 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
| Phathom Pharmaceuticals, Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $15 |
Products named: FREESTYLE LIBRE 3, OTEZLA, Dexcom G6 Transmitter, VRAYLAR, PREVNAR 20, JARDIANCE, VOQUEZNA, MOUNJARO.
Industry payments across SC — which companies pay providers there.
